Articles and science papers (unsorted part 2.3)

How the Ancient Viral DNA in Our Genome Affects Disease and Development

Human endogenous retroviruses make up 8 percent of the human genome. Researchers are studying how active they are

Gene therapy: How can poorer countries access the most expensive drugs in the world?

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses

The Effect of Glucose on Rapid Cancer Cell Proliferation & Waste

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

Doctors may have found a secret weapon to fight cancer: Viagra

Doctors may have found a secret weapon to fight cancer: Viagra

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

Nivolumab Plus Ipilimumab Vs. Chemotherapy: Survival Outcome

Blue-Green Algae Could Help Treat Cancer And Alzheimer’s Disease

A dog parasite could help fight incurable cancers—what our immunotherapy research revealed

Cholesterol-lowering drug tested for effect on prostate cancer tumors

Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin

We formerly reported that the combination of dichloroacetate, omeprazole, and tamoxifen blocked cancer progression by reducing lactic acid production and inducing superoxide production. Recently, ivermectin, a well-known anti-parasite drug, was reported to share the same mechanisms with them and have anti-tumor activity. Here, we present three patients in whom the combination of dichloroacetate, omeprazole (plus tamoxifen), and ivermectin dramatically relieved the symptoms accompanying cancer and sarcoma progression.

Anticancer, antioxidant, antiviral and antimicrobial activities of Kei Apple (Dovyalis caffra) fruit

Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells

Fenbendazole induces cell cycle arrest in colorectal cancer cells and patient-derived colon cancer organoids

Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer

Cyclodextrin Dispersion of Mebendazole and Flubendazole Improves In Vitro Antiproliferative Activity

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors

Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology

IVC ProtocolVitamin-C

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs

Effects of fenbendazole and vitamin E succinate on the growth and survival of prostate cancer cells

Anti-inflammatory ω-3 endocannabinoid epoxides

Scientists discover slug that can decapitate itself, grow new body

The bizarre discovery could pave the way for advances in regenerative medicine for humans.

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

The NALCN channel regulates metastasis and nonmalignant cell dissemination

The Race to Make a Vaccine for Breast Cancer

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization

NAD+ Helps Natural Killer Cells to Fight Cancer

Cancer fighting requires cellular energy.

Losartan – Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis

Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy

New Research: Tumor Cells Can Manipulate the Body’s Natural Antibody Response to Triple Negative Breast Cancer

Scientists find the cause of severe COVID symptoms

Anticancer effects of herbal medicines in pancreatic ductal adenocarcinoma through modulation of steroid hormone response proteins

A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy

Nivolumab Plus Ipilimumab Vs. Chemotherapy: Survival Outcome

Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials

FDA Approves New Immunotherapy Combination To Treat Advanced Liver Cancer

Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression

Compound in pomegranates may help fight colon cancer